Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse

Life Sciences

Volumn 77, Issue 14, 2005, Pages 1711-1722

  Roth, Michael D ^a   Tashkin, Donald P ^a   Whittaker, Katherine M ^a   Choi, Ruth ^a   Baldwin, Gayle Cocita ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acquired immunodeficiency syndrome; Human immunodeficiency virus; Marijuana; Tetrahydrocannabinol

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; SODIUM CHLORIDE; TETRAHYDROCANNABINOL;

ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LEUKOCYTE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CD4-CD8 RATIO; FLOW CYTOMETRY; HIV; HIV INFECTIONS; HUMANS; IMMUNITY; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; LEUKOCYTES; MICE; MICE, SCID; POLYMERASE CHAIN REACTION; RECEPTORS, CCR5; RECEPTORS, CXCR4; TETRAHYDROCANNABINOL; TIME FACTORS; VIRAL LOAD; VIRUS REPLICATION;

ANIMALIA; CANNABIS SATIVA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 23044432045     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.05.014     Document Type: Conference Paper

References (38)

1. D.I. Abrams, J.F. Hilton, R.J. Leiser, S.B. Shade, T.A. Elbeik, F.T. Aweeka, N.L. Benowitz, B.M. Bredt, B. Kosel, J.A. Aberg, S.G. Deeks, T.F. Mitchell, K. Mulligan, P. Bacchetti, J.M. McCune, and M. Schambelan Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial Annals of Internal Medicine 139 4 2003 258 266
2. J.E. Beal, R. Olson, L. Lefkowitz, L. Laubenstein, P. Bellman, B. Yangco, J.O. Morales, R. Murphy, W. Powderly, T.F. Plasse, K.W. Mosdell, and K.V. Shepard Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia Journal of Pain and Symptom Management 14 1997 7 14
3. C.C. Bleul, L. Wu, J.A. Hoxie, T.A. Springer, and C.R. Mackay The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes Proceedings of the National Academy of Sciences of the United States of America 94 1997 1925 1930
4. W.T. Caiaffa, D. Vlahov, N.M.H. Graham, J. Astemborski, L. Solomon, K.E. Nelson, and A. Munoz Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users American Journal of Respiratory and Critical Care Medicine 150 1994 1493 1498
5. H. Choe, M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates Cell 85 1996 1135 1148
6. P.R. Clapham, and R.A. Weiss Immunodeficiency viruses. Spoilt for choice of co-receptors Nature 388 1997 230 231
7. R. Condie, A. Herring, W.S. Koh, M. Lee, and N.E. Kaminski Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2 Journal of Biological Chemistry 271 22 1996 13175 13183
8. H. Deng, R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, C.B. Davis, S.C. Peiper, T.J. Schall, D.R. Littman, and N.R. Landau Identification of a major co-receptor for primary isolates of HIV-1 Nature 381 1996 661 666
9. T. Dragic, V. Litwin, G.P. Allaway, S.R. Martin, Y. Huang, K.A. Nagashima, C. Cayanan, P.J. Maddon, R.A. Koup, J.P. Moore, and W.A. Paxton HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 Nature 381 1996 667 673
10. Y. Feng, C.C. Broder, P.E. Kennedy, and E.A. Berger HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor Science 272 1996 872 877
11. M.D. Furler, T.R. Einarson, M. Millson, S. Walmsley, and R. Bendayan Medicinal and recreational marijuana use by patients infected with HIV AIDS Patient Care and STDs 18 4 2004 215 228
12. B. Gardner, L.X. Zhu, S. Sharma, Q. Liu, A. Makriyannis, D.P. Tashkin, and S.M. Dubinett Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-β Biochemical and Biophysical Research Communications 290 2002 91 96
13. B.D. Jamieson, and J.A. Zack In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus Journal of Virology 72 1998 6520 6526
14. B.D. Jamieson, and J.A. Zack Murine models for HIV disease AIDS 13 1999 S5 S11
15. K. Kedzierska, and S.M. Crowe Cytokines and HIV-1: interactions and clinical implications Antiviral Chemistry and Chemotherapy 12 2001 133 150
16. + lymphocytes induces CD4 expression and allows HIV-1 infection Journal of Virology 72 11 1998 9054 9060
17. T.W. Klein, C.A. Newton, N. Nakachi, and H. Friedman Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta2 responses to Legionella pneumophila infection Journal of Immunology 164 2000 6461 6466
18. T.W. Klein, C. Newton, K. Larsen, L. Lu, I. Perkins, L. Nong, and H. Friedman The cannabinoid system and immune modulation Journal of Leukocyte Biology 74 4 2003 486 496
19. R.J. McKallip, C. Lombard, B.R. Martin, M. Nagarkatti, and P.S. Nagarkatti Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo Journal of Pharmacology and Experimental Therapeutics 302 2 2002 451 465
20. D.E. Mosier, R.J. Gulizia, S.M. Baird, and D.B. Wilson Transfer of a functional human immune system to mice with severe combined immunodeficiency Nature 335 1988 256 259
21. D.E. Mosier, R.J. Gulizia, S.M. Baird, D.B. Wilson, D.H. Spector, and S.A. Spector Human immunodeficiency virus infection of human PBL-SCID mice Science 251 1991 791 794
22. G.R. Newell, P.W. Mansell, M.B. Wilson, H.K. Lynch, M.R. Spitz, and E.M. Hersh Risk factor analysis among men referred for possible acquired immune deficiency syndrome Preventive Medicine 14 1985 81 91
23. L. Nong, C. Newton, Q. Cheng, H. Friedman, M.D. Roth, and T.W. Klein Altered cannabiniod receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers Journal of Neuroimmunology 127 1-2 2002 169 176
24. P.K. Peterson, G. Gekker, C.C. Chao, S. Hu, C. Edelman, H.H. Balfour Jr., and J. Verhoef Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism Journal of Clinical Investigation 89 1992 574 580
25. D.D. Richman HIV chemotherapy Nature 410 2001 995 1001
26. R. Rizza, S.M. Santini, M. Logozzi, C. Lapenta, P. Sestili, G. Gherardi, R. Lande, M. Spada, S. Parlato, F. Belardelli, and S. Fais T-Cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells Journal of Virology 70 1996 7958 7964
27. M.D. Roth, G.C. Baldwin, and D.P. Tashkin Effects of delta-9- tetrahydrocannabinol on human immune function and host defense Chemistry and Physics of Lipids 121 2002 229 239
28. M.D. Roth, D.P. Tashkin, R. Choi, D.D. Jamieson, J.A. Zack, and G.C. Baldwin Cocaine enhances HIV replication in a HuPBL-SCID mouse model Journal of Infectious Diseases 185 2002 701 705
29. M.D. Roth, K. Whittaker, K. Salehi, D.P. Tashkin, and G.C. Baldwin Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers Journal of Neuroimmunology 147 2004 82 86
30. A. Shay, R. Choi, K. Whittaker, K. Salehi, D.P. Tashkin, M.D. Roth, and G.C. Baldwin Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine Journal of Infectious Diseases 187 4 2003 700 704
31. S.A. Strathdee, R.S. Hoggs, M.V. O'Shaughnessy, J.S. Montaner, and M.T. Schechter A decade of research on the natural history of HIV infection: Part 2. Cofactors Clinical and Investigative Medicine 19 1996 121 130
32. M. Tary-Lehmann, and A. Saxon Human mature T-cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood Journal of Experimental Medicine 175 1992 503 516
33. M. Tary-Lehmann, D.E. Hricik, A. Justice, N.S. Potter, and P.S. Heeger Enzyme-linked immunosorbent assay spot detection of interferon-(gamma) and interleukin 5-producing cells as a predictive marker for renal allograft failure Transplantation 66 1998 219 224
34. B. Tindall, C.R. Philpot, D.A. Cooper, J. Gold, B. Donovan, R. Penny, and T. Barnes The Sydney AIDS project: development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men Australia and New Zealand Journal of Medicine 18 1988 8 15
35. A.E. Weber, K. Chan, C. George, R.S. Hogg, R.S. Remis, S. Martindale, J. Otis, M.L. Miller, J. Vincelette, K.J. Craib, B. Masse, M.T. Schechter, R. LeClerc, R. Lavoie, B. Turmel, R. Parent, and M. Alary Risk factors associated with HIV infection among young gay and bisexual men in Canada Journal of Acquired Immune Deficiency Syndromes 28 2001 81 88
36. 9-tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells Journal of Neuroimmunology 133 1-2 2002 124 131
37. W. Zhu, H. Friedman, and T.W. Klein Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1 Journal of Pharmacology and Experimental Therapeutics 286 1998 1103 1109
38. L.X. Zhu, A. Sharma, S. Stolina, B. Gardner, M.D. Roth, D.P. Tashkin, and S.M. Dubinett Δ-9 tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway Journal of Immunology 165 1 2000 373 380